Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

NCT03793010 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Stopped By Sponsor due to occurrences of incomplete study drug administration

Conditions

Osteoarthritis, Hip

Interventions

DRUG: FX006
DRUG: Normal saline

Sponsor

Pacira Pharmaceuticals, Inc